What is INSIGHTEC?
Headquartered in Haifa, Israel, and established in 1999, INSIGHTEC operates at the intersection of advanced medical engineering and clinical practice. The company specializes in the development of incisionless magnetic resonance-guided ultrasound (MRgFUS) technology, a transformative approach that allows clinicians to perform precise therapeutic procedures without the need for traditional surgery. By leveraging real-time imaging, INSIGHTEC provides healthcare providers with the ability to treat complex conditions with high accuracy, significantly reducing patient recovery times and procedural risks. Its market position is reinforced by a long-standing history of strategic partnerships with global healthcare leaders, positioning the firm as a critical player in the evolution of modern interventional medicine.
How much funding has INSIGHTEC raised?
INSIGHTEC has raised a total of $784.9M across 8 funding rounds:
Series B
$15M
Series C
$30.9M
Series D
$59M
Series E
$150M
Other Financing Round
$150M
Debt
$200M
Private Equity
$150M
Series B (2009): $15M led by Elbit Imaging Ltd.
Series C (2012): $30.9M supported by GE Healthcare
Series D (2014): $59M featuring GE Healthcare, York Capital, Boston MedTech Advisors, and Elbit Imaging Ltd.
Series E (2017): $150M backed by Focus Holdings, Elbit Imaging Ltd., GE Healthcare, York Capital, and KDT
Other Financing Round (2020): $150M with participation from Koch
Debt (2022): $200M led by Perceptive Advisors and The Community Fund Vc
Private Equity (2024): $150M supported by Fidelity, Baillie Gifford, Nexus NeuroTech Ventures, and Ally Bridge Group
Key Investors in INSIGHTEC
Fidelity
Fidelity Investments is a global financial services firm providing comprehensive investment, wealth management, and advisory solutions to institutional and individual clients.
Baillie Gifford
Baillie Gifford is an Edinburgh-based investment management firm with a long-standing history of supporting innovative growth-stage companies.
Nexus NeuroTech Ventures
Nexus NeuroTech Ventures is a specialized investment firm focused on accelerating breakthrough technologies for neurological and psychiatric disorders.
What's next for INSIGHTEC?
With the recent influx of capital, INSIGHTEC is well-positioned to accelerate its R&D pipeline and scale its commercial operations. The company is expected to focus on broadening the clinical applications of its ultrasound technology, targeting new therapeutic areas that require high-precision, non-invasive interventions. By leveraging its robust intellectual property portfolio and deep-rooted industry relationships, INSIGHTEC aims to solidify its leadership in the neurotechnology and interventional radiology sectors, ultimately driving the adoption of incisionless procedures as a standard of care in global clinical environments.
See full INSIGHTEC company page
